# To Study the Safety and Efficacy of Autologous Bone Marrow Stem Cells in Patients With Spinal Cord Injury

> **NCT01730183** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Max Institute of Neurosciences** · enrollment: 15 (estimated)

## Conditions studied

- Spinal Cord Injury

## Interventions

- **OTHER:** Bone marrow derived stem cells

## Key facts

- **NCT ID:** NCT01730183
- **Lead sponsor:** Max Institute of Neurosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-11
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2012-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01730183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01730183, "To Study the Safety and Efficacy of Autologous Bone Marrow Stem Cells in Patients With Spinal Cord Injury". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01730183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*